The Berlin Institute of Health (BIH), together with the Charité - Universitätsmedizin Berlin, has set up an interdisciplinary study program consisting of a series of basic and clinical studies, which aim to expand knowledge about the new coronavirus and its health consequences as well as therapy options as quickly as possible. Using state-of-the-art methods - such as mass spectrometry, single-cell sequencing and high-throughput immunocharacterization - for example, the researchers are investigating the changes SARS-CoV-2 causes in the body. The research projects also shed light on the role of the heart and immune system in the disease process. The studies also focus on possible secondary damage and its prevention. Last but not least, a number of therapy options are being examined.
In order to best promote research into SARS-CoV-2 and COVID-19 at the Charité and the BIH, the newly established Charité/BIH COVID-19 Research Board coordinates all research projects. Staffed by experts from a wide range of disciplines, it aims to promote synergies, make the use of scarce biomaterials as efficient as possible, and enable joint access to technologies.
Robert Koch Institute (RKI)
Up-to-date information on the novel coronavirus (e.g. symptoms, risk of infection, preventive measures) can be found on the website of the Robert Koch Institut.
Coronavirus update with BIH professor Christian Drosten on NDR
Prof. Christian Drosten, Director of the Institute of Virology at the Charité, gives a daily update on the coronavirus in the NDR Podcast.
Educational Ressources in the Corona Break
Make the best out of the Corona break and find helpful tools and courses for your research, compiled by QUEST Center. The Center also provides a continuously updated overview of resources on COVID-19 and Patient & Stakeholder Engagement.
Time for 3R
For the Corona period, Charité 3R has compiled tips on how to improve your research projects by 3R-related online resources.